Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Helen Giza is the Chief Executive Officer of Fresenius Medical Care, a global leader in providing products and services for individuals with renal diseases. Appointed as CEO in December 2022, Giza has played a critical role in leading the company’s strategic transformation, leveraging her extensive background in healthcare and finance.
Giza joined Fresenius in 2019 as Chief Financial Officer and later took on the role of Deputy CEO and Chief Transformation Officer in 2022, leading the FME25 transformation program aimed at optimizing performance. Her leadership has been central in positioning the company for operational turnaround and future growth. Before Fresenius, she served as Chief Integration and Divestiture Management Officer at Takeda Pharmaceuticals, and she held various leadership roles in finance at Abbott Laboratories and TAP Pharmaceuticals.
A UK Chartered Certified Accountant, Giza earned her MBA from the Kellogg School of Management at Northwestern University. Her experience spans global healthcare leadership and financial expertise, making her a vital asset to Fresenius’s continued mission of enhancing patient care and operational excellence.
